Treating Asthma in the Older Patient: Is There a Place for Leukotriene Modifiers?

Author： Grayson Mitchell H.   Korenblat Phillip E.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.6, 2006-01, pp. : 451-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukotriene Modifiers and Churg-Strauss Syndrome: Adverse Effect or Response to Corticosteroid Withdrawal?

By Wechsler M.E.  

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 241-251

Adis International

Access to resources Recommend Favorite

Antileukotriene Drugs in Childhood Asthma: What is Their Place in Therapy?

By Selvadurai H.   Mellis C.  

Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. : 367-372

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

By Heaton Pamela C.  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 727-742

Adis International

Access to resources Recommend Favorite

Antivirals for Influenza: What Is Their Role in the Older Patient?

By Dumyati G.   Falsey A.R.  

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 777-786

Adis International

Access to resources Recommend Favorite

Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?

By Locatelli Francesco  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1277-1280

Informa Healthcare

Access to resources Recommend Favorite